Leerink Partners Remains Sidelined on Agios Pharma (AGIO) - PT to $56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share
February 18, 2016 7:15 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... MoreTrading Radar for 2/18: Wal-mart (WMT), Cabela's (CAB), Nordstrom (JWN), Leidos (LDOS), SodaStream (SODA) Report
February 17, 2016 3:18 PM EST(Updated - February 17, 2016 3:19 PM EST)
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.78
Aaron's (NYSE: AAN) - consensus EPS $0.38
Agios Pharma (Nasdaq: AGIO) - consensus loss $0.50
Atlas Air Worldwide... More
